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Abstract
Background and objective Maintenance of genomic integrity is essential to ensure normal organismal development and to 
prevent diseases such as cancer. PR-Set7 (also known as Set8) is a cell cycle regulated enzyme that catalyses monomethylation 
of histone 4 at Lys20 (H4K20me1) to promote chromosome condensation and prevent DNA damage. Recent studies show that 
CRL4CDT2-mediated ubiquitylation of PR-Set7 leads to its degradation during S phase and after DNA damage. This might 
occur to ensure appropriate changes in chromosome structure during the cell cycle or to preserve genome integrity after DNA 
damage. Methods We developed a new model of lung tumor development in mice harboring a conditionally expressed allele of 
Cul4A. We have therefore used a mouse model to demonstrate for the first time that Cul4A is oncogenic in vivo. With this model, 
staining of PR-Set7 in the preneoplastic and tumor lesions in AdenoCre-induced mouse lungs was performed. Meanwhile we 
identified higher protein level changes of γ-tubulin and pericentrin by IHC. Results The level of PR-Set7 down-regulated in the 
preneoplastic and adenocarcinomous lesions following over-expression of Cul4A. We also identified higher levels of the proteins 
pericentrin and γ-tubulin in Cul4A mouse lungs induced by AdenoCre. Conclusion PR-Set7 is a direct target of Cul4A for 
degradation and involved in the formation of lung tumors in the conditional Cul4A transgenic mouse model.
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Introduction
Lung cancer is t he lead ing cause of cancer deat hs 
worldwide[1]. The central role of CRL4Cdt2 in regulating the 
expression of various proteins that regulate the cell cycle, and 
its role in determining the integrity of DNA replication and 
repair, suggest that various components of CRL4Cdt2 could 
be involved in tumorigenesis[2]. In mammals, the Cul4 family 
has another member, Cul4B, which shares 89% sequence 
homology and some functional redundancy with Cul4A[3-5]. 
T he i mpor ta nce of cel l c ycle med iators i n hu ma n 
carcinogenesis is now well established[6]. We already showed 
that Cul4A is oncogenic in vivo and that over-expression 
of Cul4A leads to tumorigenesis in the mouse lung[7]. 
However, the relationship between Cul4A induced lung 
tumor occurrence and cell cycle remains to be determined. 
In our experiments, we used Cre-recombinase-induced 
overexpression of the Cul4A gene in transgenic mice to 
explore relationship between the Cul4A gene and DNA re-
replication and genomic instability. Meanwhile, we will also 
investigate the effect of PR-Set7, the key regulator of genomic 
stability in mouse lung tumors. Finally, we will validate 
elevated protein levels of pericentrin and γ-tubulin in mouse 
lungs with Cul4A over-expression, as elevated levels of these 
proteins often indicate an increase in chromosome number, 
an event associated with human lung carcinogenesis. 
Materials and methods
AdenoCre induction in Cul4A transgenic mice
Mice were infected with AdenoCre or Ade-GFP at 6-10 
weeks of age. The study was approved by the University of 
California at San Francisco (UCSF) Institutional Animal 
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Care and Use Committee. The intranasal administration 
o f  t h e  a d e no v i r u s e s  w a s  p e r f o r me d  a s  p r e v i o u s l y 
described[8]. The AdenoCre (Ad5CMVCre) and Ade-GFP 
(Ad5CMVeGFP) were purchased from the Gene Transfer 
Vector Core of the University of Iowa, and have been used 
in several studies[9]. To generate a mouse model that would 
conditionally over-express Cul4A protein, we used the 
pCALL2 vector[10]. Transgenic mice were anesthetized with 
2.5% Avertin via intraperitoneal injection, after which half 
of the mice inhaled approximately 106 or 107 particles of 
AdenoCre introduced directly into the lungs. The other half 
inhaled Ade-GFP without AdenoCre. Eight weeks later, the 
mice were killed, and the lungs were dissected and sections 
analyzed.
Histological analysis and immunohistochemistry
Animals were killed at the post-infection times indicated 
a nd subjec ted to f u l l  nec rops y for h i stolog ic a l  a nd 
immunohistochemical analyses. Sections were blocked with 
4% normal goat serum in PBS with 0.2% Triton for 2 h at RT 
before incubating overnight at 4 ºC with the properly diluted 
antibodies: anti-PRSet7 1:100 (2996, CellSignaling); anti-γ 
tubulin 1:5,000 (ab11317, Abcam); anti-pericentrin 1:2,000 
(ab4448, Abcam).
Immunohistochemical analyses and statistical analysis
Correlation analyses were performed using SPSS 13.0 
(SPSS Inc, Chicago, IL, USA). We used 0, 1, 2, and 3 as 
representatives of -, +, ++, and +++, respectively. The 
following scoring system was employed: -, no stain; +, weak 
staining (10% or above stained cellularity considered as 
positive); ++, moderate staining (30% or above stained 
cellularity considered as positive); +++, strong staining 
(positive). All scoring systems were under low magnification 
(×10).
Results 
The overt adenocarcinomas (AD) were present since 20 wk 
post-infection with AdenoCre
  Infected Lox-Stop-Lox Cul4A mice (hereafter referred 
to as Lox-Cul4A) were killed at 8, 12, 16, 20, 24 and 24 wk 
post-infection. At 20 wk post-infection with AdenoCre, the 
surface of Lox-Cul4A lungs had a cobblestone appearance, 
and histological sections showing a single lesion. At 24 wk 
post-infection with AdenoCre, visible tumors were clearly 
Figure 1  Tumor pathology in Cul4A over-expression mouse lungs. A: Wild-type mouse lungs 8 wk post-infection with Ade-GFP. The surface of the 
lungs is smooth and uniform. B: Lox-Cul4A mouse lungs 12 wk post-infection with AdenoCre. The surface of the lungs is also smooth and uniform. 
C: Lox-Cul4A mouse lungs 16 wk post-infection with AdenoCre. The surface of the lungs has a bumpy appearance, arrows indicate the lesions. D: 
Lox-Cul4A mouse lungs 20 wk post-infection with AdenoCre. An isolated cobblestone-like nodule on the surface of the lungs is visible; the arrow 
indicates the lesion. E: Lox-Cul4A mouse lungs 24 wk post-infection with AdenoCre. Several nodules on the surface of the lungs have appeared; 
arrows indicate the lesions. F: Histological sections of wild-type mouse lungs 8 wk post-infection with AdenoCre (HE). G: Histological sections of 
Lox-Cul4A mouse lungs 12 wk post-infection with AdenoCre; the arrow shows a single lesion (HE). H: Histological sections of Lox-Cul4A mouse 
lungs 16 wk post-infection with AdenoCre; arrows indicate isolated lesions (HE). I: Histological sections of Lox-Cul4A mouse lungs 20 wk post-
infection with AdenoCre; arrow shows a single adenocarcinoma-like lesion (HE). J: Histological sections of Lox-Cul4A mouse lungs 24 wk post-
infection with AdenoCre; arrows show diffuse severe adenocarcinoma-like lesions (HE). Scale bar indicates 200 μm.
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seen on the surface of the Lox-Cul4A mouse lungs, with 
numerous severe isolated adenocarcinoma-like lesions visible 
under a microscope (Fig 1). 
Cul4A promotes PR-Set7 degradation: immunohistochemical 
analysis
  Stainings of PR-Set7 in mouse lung sections induced 
with Ade-GFP were weakly to moderately positive across all 
time points (Fig 2A, C, E); whereas stainings of PR-Set7 in 
the preneoplastic and tumor lesions in AdenoCre-induced 
mouse lungs was either weakly positive or else negative 
across all time points (Fig 2B, D, F).
Up-regulation of γ-tubulin and pericentrin were found in 
Lox-Cul4A mouse lungs induced by AdenoCre
The protein level change of γ-tubulin and pericentrin in 
Cul4A mouse lungs induced by AdenoCre were both higher 
than those of mouse lungs induced with Ade-GFP (Fig 3).
Discussion
To determine whether over-expression of Cul4A results 
in degradation of PR-Set7 expression, we compared the 
PR-Set7 expression in lung tumors and control lungs by 
using IHC analysis. To maintain genome integrity, DNA 
replication must be tightly regulated so that replication only 
initiates once at each replication origin during S phase. Here, 
we investigated the expression of PR-Set7 following the gain-
of-function of Cul4A in the progression of mouse lung tumor. 
Staining of PR-Set7 in mouse terminal bronchiole epithelial 
cells induced with Ade-GFP were between weak moderate 
positive (++) and strong positive (+++) across all time points. 
Staining of Set8 in the preinvasive and adenocarcinomous 
lesions in AdenoCre-induced mouse lungs was weak positive 
(+) or negative (-) across all time points. These results gave 
rise to the hypothesis that the initiation and progression 
of mouse lung tumor elicited by over-expression of Cul4A 
Figure 2  Immunostainings of PR-Set 7 in the mouse lung 
sections at the indicated time. A: 8 wk with Ade-GFP (SP). 
B: 8 wk with AdenoCre (SP). C: 12 wk with Ade-GFP (SP). D: 
12 wk with AdenoCre (SP). E: 16 wk with Ade-GFP (SP). F: 
16 wk with AdenoCre (SP). 
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was through degradation of PR-Set7. Similar to CDT1 
(data not shown), with this mouse model, we identified that 
Cul4A as the principal E3 ubiquitin ligase responsible for 
PR-Set7 proteolytic degradation. Interestingly, a recent 
study also determined that Set8 (PR-Set7) ubiquitination 
by SCFSkp2, and subsequent degradation of PR-Set7 at G1, 
were associated with S-phase entry[11]. Lack of PR-Set7, as 
the methyltransferase that monomethylates histone H4 on 
lysine 20 (H4K20me1)[12], results in massive DNA damage 
during S phase and improper chromosome condensation in 
mitosis[13,14]. During the cell cycle, PR-Set7 is most abundant 
du r i ng G 2 a nd M phases, a nd low du r i ng S phase
[15]. 
Concomitant with its increase in the G2 and M phases, PR-
Set7 promotes a transient accumulation of H4K20me1[13]. 
H4K20me1, which promotes chromatin condensation, may 
be necessary for proper mitosis, and may also impact the 
subsequent S phase. As our results showed that PR-Set7 
is degraded in response to over-expression of Cul4A, we 
propose that Cul4A-mediated degradation of PR-Set7 in the 
preinvasive lesions in mouse lung sections induced might 
prevent H4K20me1 accumulation during S phase, thereby 
preventing premature chromatin condensation. We believe 
that this interferes with genome duplication, induces DNA 
damage, and activates the p53 tumor suppressor pathway 
(data not shown). Importantly, these reports demonstrate 
that inappropriate levels of PR-Set7 in this mouse model 
could result in profound cell cycle defects including the 
inability to initiate S phase, the re-replication of DNA, and 
the improper timing of mitotic progression. The replication-
coupled down-regulation of PR-Set7 is a critical mechanism 
that defines the functional window of PR-Set7 during the 
cell cycle, contributing to the orderly execution of DNA 
replication and mitosis.
Here we described an efficient method for evaluation of 
Figure 3  Immunostainings of pericentrin and γ-tubulin in mouse lung sections. A: 8 wk with Ade-GFP (SP). B: 8 wk with AdenoCre (SP). C: 12 wk 
with Ade-GFP (SP). D: 12 wk with AdenoCre (SP). E: 16 wk with Ade-GFP (SP). F: 16 wk with AdenoCre (SP). G: 8 wk with Ade-GFP (SP). H: 8 wk with 
AdenoCre (SP). I: 12 wk with Ade-GFP (SP). J: 12 wk with AdenoCre (SP). K: 16 wk with Ade-GFP (SP). L: 16 wk with AdenoCre (SP). Scale bar, 100 μm.
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the centrosome amplification by quantifying the protein 
levels of γ-t ubu l in and per icentr in, t wo const it ut ive 
cent rosoma l protei n. T he f u nct ion of γ-t ubu l i n was 
clearly determined by purif ication of the tubulin r ing 
complex (Gamma-TuRC) that revealed a ring shape and a 
substructure able to nucleate microtubule polymerization in 
vitro[16]. Increased accumulation of microtubules, observed 
in reconstructed eggs, may also play a role in centrosome 
dysfunctions by causing abnormal microtubule organization 
and aneuploidy[17]. It is also reported that the prognosis 
of bladder cancer is significantly worse with centrosome 
amplification than without. Thus, evaluation of centrosome 
abnormality could be used as a prognostic biomarker for 
the progression and recurrence of cancer[18]. Various types 
of genetic lesions can be found in cancer cells, including 
DNA sequence mutations (i .e. point mutation, insertion 
a nd delet ion, recombi nat ion, etc .) a nd ch romosome 
mutations [i.e. translocation, double-minute chromosomes, 
aneuploidy (chromosome loss and gain), etc.][19]. Although 
it is apparently meaningless for us to label which type of 
mutation is most important for carcinogenesis in this mouse 
model, it is clear that aneuploidy inf luences the rate of this 
mouse model tumor progression to a great extent, since 
gain of even a single chromosome can introduce multiple 
mutations required for acquisition of malignant phenotypes. 
We were unable to determine the causes for centrosome 
number increases in the mouse model, but loss of cell cycle 
regulators such as p21 (data not shown) may be related to 
supernumerary centrosomes. 
In this paper, we further validated that key regulator of 
genome stability, PR-Set7 is involved in the development 
of mouse lung tumors, and found high protein levels of 
pericentrin and γ-tubulin in mouse lung tumors. Future 
studies are required to test this possibility and others to 
clarify the cellular and molecular underpinnings of the 
disorders associated with elevated levels of pericentrin and 
γ-tubulin in human lung cancers. A better understanding of 
Cul4A signaling pathways and mechanisms and their effects 
on the growth of lung tumors in our mouse model could 
provide new insight, thus contributing to future experimental 
therapies.
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